Abstract
Objective: The etiology of most cases of myelodysplastic syndromes (MDS) has not been elucidated. We have undertaken an investigation in Greece to determine the risk profile of adult de-novo MDS. Methods: A case–control investigation was conducted in a large Veterans' hospital over a five-year period, covering 84 MDS cases and 84 age- and gender-matched controls with minor non-neoplastic non-infectious conditions from the same study base. Cases and controls reported to the medically trained principal investigator lifestyle characteristics and medical histories, with emphasis on autoimmune disorders and allergic conditions. Results: Alcohol intake and tobacco smoking jointly increased significantly the risk of MDS (odd ratio contrasting ever smokers and regular drinkers of at least one glass per day to never smokers and drinkers of less than one glass per day: 9.54, 95% CI 3.52–25.82) whereas each of these factors alone had limited effect. There was also evidence that autoimmune conditions, but not allergic disorders, were positively associated with MDS risk, irrespective of their occurrence during the recent (less than ten years) or the remote (more than ten years) past (OR 3.34, 95% CI 1.15–9.74; OR 3.50, 95% CI 1.19–10.26, respectively). Conclusion: We found evidence that both exogenous and endogenous factors may play a role in the etiology of the so-called “de novo” myelodysplastic syndromes, but these findings need further confirmation.
Similar content being viewed by others
References
Block M, Jacobsen LO, Bethard WF (1953) Preleukemic acute human leukemia. JAMA 152: 1018–1028.
Rheingold JJ, Kaufman R, Adelson E, Lear A (1963) Smoldering acute leukemia. N Engl J Med 268: 812–815.
List AF, Doll DF (1999) The myelodysplastic syndromes. In: Foerster GR, Lukens LJ, Paraskevas F, Greer JP, Rodgers GM, eds. Wintrobe's Clinical Hematology, 10th edn. Baltimore: Williams & Wilkins, pp. 2320–2333.
Aul C, Germing U, Gattermann N, Minning H (1998) Increasing incidence of myelodysplastic syndromes: real or fictitious? Leuk Res 22: 93–100.
San Miguel JF, Sanz GF, Vallespi T, del Canizo MC, Sanz MA (1996) Myelodysplastic syndromes. Crit Rev Oncol Hematol 23: 57.
Ahmad YH, Kiehl R, Papac RJ (1995) Myelodysplasia: the clinical spectrum of 51 patients. Cancer 76: 869–874.
Aul C, Gattermann N, Schneider W (1992) Age-related incidence and other epidemiologic aspects of myelodysplastic syndromes. Br J Haematol 82: 358.
Bennett M, Catovsky D, Daniel MT, Flandrin G, Galton DA, Granlick HR, Sultan S (1982) Proposals for the classification of MDS. Br J Haematol 51: 189.
Pasqualetti P, Festuccia V, Acitelli P, Collacciani A, Giusti A, Casale R (1997) Tobacco smoking and risk of hematological malignancies in adults: a case-control study. Br J Haematol 97: 659–662.
Bjork J, Albin M, Mauritzon N, Stromberg U, Johansson B, Hagmar L (2000) Smoking and myelodysplastic syndromes. Epidemiology 11: 285–291.
Ido M, Nagata C, Kawakami N, et al. (1996) A case-control study of myelodysplastic syndromes among Japanese men and women. Leuk Res 20: 727–731.
Isomaki HA, Hakulinen T, Jousenlanti U (1978) Excess risk of lymphomas, leukemia and myeloma in patients with rheumatoid arthritis. J Chron Dis 31: 691–696.
Morimoto C, Reinherz EL, Schlossman SF, Mills JA, Steinberg AD (1980) Alterations in immunoregulatory T cell subsets in active systemic lupus erythematosus. J Clin Invest 66: 1171–1174.
Talal N, Bunim JJ (1964) The development of malignant lymphoma in the course of Sjogren's syndrome. Am J Med 36: 529–540.
Sridama V, Pacini F, DeGroat LJ (1982) Decreased suppressor Tlymphocytes in autoimmune thyroid diseases detected by monoclonal antibodies. J Clin Endocrinol Metab 54: 316–319.
Luraschi A, Saglietti G, Fedeli P, et al. (1994) Immunologic indices in myelodysplastic syndromes. Minerva Med 85: 145–153.
Enright H, Miller W (1997) Autoimmune phenomena in patients with myelodysplastic syndromes. Leuk Lymph 24: 483–489.
Okamoto T, Okada M, Mori A (1997) Correlation between immunological abnormalities and prognosis in myelodysplastic syndrome patients. Int J Hematol 66: 345–351.
Breslow NE, Day NE (1980) Statistical Methods in Cancer Research, Vol. I: The Analysis of Case-Control Studies. Lyon: International Agency for Research on Cancer, IARC Scientific Publications No 32.
Beris P (1989) Primary clonal myelodysplastic syndromes. Semin Hematol 26: 216–233.
Adami J, Nyren O, Bergstrom R, et al. (1998) Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control 9: 49–56.
Severson RK (1987) Cigarette smoking and leukemia. Cancer 60: 141–144.
Kane EV, Roman E, Cartwright R, Parker J, Morgan G (1999) Tobacco and the risk of acute leukaemia in adults. Br J Cancer 81: 1228–1233.
Casagrande G, Michot F (1989) Alcohol-induced bone marrow damage; status before and after a 4-week period of abstinence from alcohol with or without disulfiram. A randomized bone marrow study in alcohol-dependent individuals. Blut 59: 231–236.
Nagata C, Shimizu H, Hirashima K, et al. (1999) Hair dye use and occupational exposure to organic solvents as risk factors for myelodysplastic syndrome. Leuk Res 23: 57–62.
Trichopoulos D (1974) Medical Statistics: Principles and Basic Methods of Biomedical Statistics. In: Parisianos Scientific Editions (Greek). Athens, pp. 63–81.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Dalamaga, M., Petridou, E., Cook, F.E. et al. Risk factors for myelodysplastic syndromes: a case–control study in Greece. Cancer Causes Control 13, 603–608 (2002). https://doi.org/10.1023/A:1019573319803
Issue Date:
DOI: https://doi.org/10.1023/A:1019573319803